BACKGROUND: The effectiveness of collaborative care for patients with major depressive disorder in primary care has been established. Assessing its cost-effectiveness is important for deciding on implementation. This review therefore evaluates the cost-effectiveness of collaborative care for major depressive disorder in primary care. METHODS: A systematic search on economic evaluations of collaborative care was conducted in Pubmed and PsychInfo. Quality of the studies was measured with the Cochrane checklist and the CHEC-list for economic evaluations. Cost-effectiveness and costs per depression-free days were reported. RESULTS: 8 studies were found, involving 4868 patients. The quality of the cost effectiveness studies, according to the CHEC-list, could be improved. Generally, the studies did not include all relevant costs and did not perform sensitivity analysis. Only 4 out of 8 studies reported cost per QALY, 6 out of 8 reported costs per depression-free days. The highest costs per QALY reported were $49,500, the highest costs per depression-free day were $24. CONCLUSIONS: Although studies did not fulfil all criteria of the CHEC-list, collaborative care is a promising intervention and it may be cost-effective. However, to conclude on the cost-effectiveness, depression research should follow economic guidelines to improve the quality of the economic evaluations.
BACKGROUND: The effectiveness of collaborative care for patients with major depressive disorder in primary care has been established. Assessing its cost-effectiveness is important for deciding on implementation. This review therefore evaluates the cost-effectiveness of collaborative care for major depressive disorder in primary care. METHODS: A systematic search on economic evaluations of collaborative care was conducted in Pubmed and PsychInfo. Quality of the studies was measured with the Cochrane checklist and the CHEC-list for economic evaluations. Cost-effectiveness and costs per depression-free days were reported. RESULTS: 8 studies were found, involving 4868 patients. The quality of the cost effectiveness studies, according to the CHEC-list, could be improved. Generally, the studies did not include all relevant costs and did not perform sensitivity analysis. Only 4 out of 8 studies reported cost per QALY, 6 out of 8 reported costs per depression-free days. The highest costs per QALY reported were $49,500, the highest costs per depression-free day were $24. CONCLUSIONS: Although studies did not fulfil all criteria of the CHEC-list, collaborative care is a promising intervention and it may be cost-effective. However, to conclude on the cost-effectiveness, depression research should follow economic guidelines to improve the quality of the economic evaluations.
Authors: Dick Bijl; Harm W J van Marwijk; Marten de Haan; Willem van Tilburg; Aart-Jan T F Beekman Journal: Eur J Gen Pract Date: 2004-03 Impact factor: 1.904
Authors: Jürgen Unützer; Wayne Katon; Christopher M Callahan; John W Williams; Enid Hunkeler; Linda Harpole; Marc Hoffing; Richard D Della Penna; Polly Hitchcock Noël; Elizabeth H B Lin; Patricia A Areán; Mark T Hegel; Lingqi Tang; Thomas R Belin; Sabine Oishi; Christopher Langston Journal: JAMA Date: 2002-12-11 Impact factor: 56.272
Authors: G E Simon; W J Katon; M VonKorff; J Unützer; E H Lin; E A Walker; T Bush; C Rutter; E Ludman Journal: Am J Psychiatry Date: 2001-10 Impact factor: 18.112
Authors: Anton C M Vergouwen; Abraham Bakker; Wayne J Katon; Theo J Verheij; Frank Koerselman Journal: J Clin Psychiatry Date: 2003-12 Impact factor: 4.384
Authors: Ronald C Kessler; Patricia Berglund; Olga Demler; Robert Jin; Doreen Koretz; Kathleen R Merikangas; A John Rush; Ellen E Walters; Philip S Wang Journal: JAMA Date: 2003-06-18 Impact factor: 56.272
Authors: Leif I Solberg; A Lauren Crain; Michael V Maciosek; Jürgen Unützer; Kris A Ohnsorg; Arne Beck; Lisa Rubenstein; Robin R Whitebird; Rebecca C Rossom; Pamela B Pietruszewski; Benjamin F Crabtree; Kenneth Joslyn; Andrew Van de Ven; Russell E Glasgow Journal: Ann Fam Med Date: 2015-09 Impact factor: 5.166
Authors: Maureen T Stewart; Constance M Horgan; Amity E Quinn; Deborah W Garnick; Sharon Reif; Timothy B Creedon; Elizabeth L Merrick Journal: Adm Policy Ment Health Date: 2017-11
Authors: Christopher J Miller; Kevin N Griffith; Kelly Stolzmann; Bo Kim; Samantha L Connolly; Mark S Bauer Journal: Med Care Date: 2020-10 Impact factor: 2.983
Authors: John B Jolly; Norman R Fluet; Michael D Reis; Charles H Stern; Alexander W Thompson; Gillian A Jolly Journal: Proc (Bayl Univ Med Cent) Date: 2016-04
Authors: Maartje Goorden; Moniek C Vlasveld; Johannes R Anema; Willem van Mechelen; Aartjan T F Beekman; Rob Hoedeman; Christina M van der Feltz-Cornelis; Leona Hakkaart-van Roijen Journal: J Occup Rehabil Date: 2014-09